Formulation and evaluation of olanzapine matrix pellets for controlled release

DARU, Journal of Pharmaceutical Sciences

Volumn 19, Issue 4, 2011, Pages 249-256

  Vishal Gupta, N ^a   Gowda, D V ^a   Balamuralidhara, V ^a   Mohammed Khan, S ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

Microporous membrane; Pelletization; Release kinetics; SEM

Indexed keywords

ALGINIC ACID; DODECYL SULFATE SODIUM; GLYCEROL PALMITOSTEARATE; MICROCRYSTALLINE CELLULOSE; OLANEX; OLANZAPINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG PELLET; DRUG RELEASE; DRUG SCREENING; INFRARED SPECTROSCOPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

EID: 80054798980     PISSN: 15608115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Maxine XP, Anthony SD. Why aren't depot antipsychotics prescribed more often and what can be done about it. Adv. Psych. Treat., 2005; 11: 203-211.
2. Tollefson GD, Sanger TM. Negative Symptoms: a path analytic approach to a double-blind, placebo-and haloperidol-controlled clinical trial with olanzapine. Am. J. Psychiatry, 1997; 4: 154-164.
3. Lerner V. High-dose olanzapine for treatment-refractory schizophrenia. Clin. Neuropharmacol., 2003; 26: 58-61.
4. Kurtz D, Bergstrom R, McDonnell D, Mitchell M. Pharmacokinetics (PK) of multiple doses of olanzapine long-acting injection (OLAI), an intramuscular (IM) depot formulation of olanzapine (OLZ), in stabilized patients with schizophrenia. Biol. Psychiatry, 2008; 63: 228-235.
5. Masazumi K, Hiroaki N. Development of controlled release matrix pellets by annealing with micronized water-insoluble or enteric polymers, J. Contr. Rel., 2002; 82: 335-343.
6. Ponghanaghakul T, Puttipipatkhachorn S. Alginate-magnesium aluminum silicate film: Effect of plasticizer film properties, drug permeation and drug release from coated tablets. Int. J. Pharm., 2007; 333: 34-44.
7. rd ed. London: Association of Pharmaceutical society of Great Britain. 2000.
8. Chauhan B, Shimpi S, Paradkar A. Preparation and characterization of etoricoxib solid dispersions using lipid carriers by spray drying technique. AAPS Pharm. Sci. Tech., 2005; 6: 48-55
9. Fieldman E, Newton JM. Encyclopedia of pharmaceutical technology, New York, Marcel Dekker. 2002; 399-417.
10. Pongajanyakul T, Natalie JM, Ian TG. Melted glyceryl palmito stearate pellets for protein delivery. Int.J. Pharm., 2004; 271: 53-62.
11. Kleinebudde P. The crystallite-gel-model for microcrystalline cellulose in wet granulation, extrusion and spheronization. Pharm. Res., 1997; 14: 804-809.
12. Repka MA, Sunil KB, Sampada UB, Sridhar T, Michael CM, Feng Z, Charles M, McGnity JW. Pharmaceutical application of hot melt extrusion-part II. Drug. Dev. Ind. Pharm., 2007; 33: 1043-1057.
13. Gowda DV, Rajesh N, Afrasim M, Shivakumar HG, Siddaramaiah H. Controlled release behaviour of nifedipine from the pellets of gellucire/ microcrystalline cellulose blends. Int. J. Pharm Tech. Res., 2010; 2: 1215-1226.
14. Prameela RA, Bala SC. Development of HPLC method for the determination of olanzapine in bulk and dosage forms. Int. J. Pharm. Tech. Res., 2009; 1: 654-657.
15. Siepmann F, Muschert S, Flament MP, Leterme P, Gayot A, Siepmann A. Controlled drug release from gelucire based matrix pellets: experiment and theory. Int. J. Pharm., 2006; 317: 136-143.
16. Basist AW, Newton JM., Lacey LF. Formulation of ranitidine pellets by extrusion spheronization with little or no microcrystalline cellulose. Pharm. Dev. Tech., 1999; 4: 499-505.
17. Gowda DV, Rajesh N, Shivakumar HG, Siddaramaiah Nawaz M. Development and evaluation of oral controlled release aceclofenac sodium pellets. Pharm. Sci. Monit., 2011; 2: 82-104.
18. Gowda DV, Ravi V, Shivakumar HG, Siddaramaiah H. Preparation, evaluation and bioavailability studies of indomethacin bees wax microspheres. J. Mater. Sci. Mater. Med., 2009; 20: 1447-1456.
19. Manisha T, Garima C, Arvind KB. Quantification of olanzapine polymorphs using powder X-ray diffraction technique. J. Pharm. Biomed. Anal., 2007; 43: 865-872.
20. Kulkarni AS, Ghadge DM, Kokate PB. Formulation and in vitro evaluation of orally disintegrating tablets of olanzapine-2-hydroxypropyl-β-cyclodextrin inclusion complex. Iran. J. Pharma. Res., 2010; 9: 335-347.
21. Rajesh KS, Khanrah A, Biswanath S. Release of ketoprofen from alginate microparticles containing film forming polymers. J. Sci. Ind. Res., 2003; 27: 965-989